These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33377052)

  • 21. Pipeline for the Generation and Characterization of Transgenic Human Pluripotent Stem Cells Using the CRISPR/Cas9 Technology.
    Mianné J; Bourguignon C; Nguyen Van C; Fieldès M; Nasri A; Assou S; De Vos J
    Cells; 2020 May; 9(5):. PubMed ID: 32466123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generating CRISPR-Cas9-Mediated Null Mutations and Screening Targeting Efficiency in Human Pluripotent Stem Cells.
    Bower OJ; McCarthy A; Lea RA; Alanis-Lobato G; Zohren J; Gerri C; Turner JMA; Niakan KK
    Curr Protoc; 2021 Aug; 1(8):e232. PubMed ID: 34432381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Id3 is a direct transcriptional target of Pax7 in quiescent satellite cells.
    Kumar D; Shadrach JL; Wagers AJ; Lassar AB
    Mol Biol Cell; 2009 Jul; 20(14):3170-7. PubMed ID: 19458195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Derivation and FACS-mediated purification of PAX3+/PAX7+ skeletal muscle precursors from human pluripotent stem cells.
    Borchin B; Chen J; Barberi T
    Stem Cell Reports; 2013; 1(6):620-31. PubMed ID: 24371814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myogenic progenitor specification from pluripotent stem cells.
    Magli A; Perlingeiro RRC
    Semin Cell Dev Biol; 2017 Dec; 72():87-98. PubMed ID: 29107681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR/Cas9-based Targeted Genome Editing for the Development of Monogenic Diseases Models with Human Pluripotent Stem Cells.
    Gupta N; Susa K; Yoda Y; Bonventre JV; Valerius MT; Morizane R
    Curr Protoc Stem Cell Biol; 2018 May; 45(1):e50. PubMed ID: 30040245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscle cell identity requires Pax7-mediated lineage-specific DNA demethylation.
    Carrió E; Magli A; Muñoz M; Peinado MA; Perlingeiro R; Suelves M
    BMC Biol; 2016 Apr; 14():30. PubMed ID: 27075038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of skeletal myogenic progenitors from human pluripotent stem cells using non-viral delivery of minicircle DNA.
    Kim J; Oliveira VKP; Yamamoto A; Perlingeiro RCR
    Stem Cell Res; 2017 Aug; 23():87-94. PubMed ID: 28732241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protocol for genome-scale CRISPR screening in engineered lineage reporter hPSCs to study cell fate determination.
    Zhou Z; Ma L; Zhang X
    STAR Protoc; 2021 Jun; 2(2):100548. PubMed ID: 34095862
    [No Abstract]   [Full Text] [Related]  

  • 30. Derivation of Skeletal Myogenic Precursors from Human Pluripotent Stem Cells Using Conditional Expression of PAX7.
    Darabi R; Perlingeiro RC
    Methods Mol Biol; 2016; 1357():423-39. PubMed ID: 25403466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly efficient generation of isogenic pluripotent stem cell models using prime editing.
    Li H; Busquets O; Verma Y; Syed KM; Kutnowski N; Pangilinan GR; Gilbert LA; Bateup HS; Rio DC; Hockemeyer D; Soldner F
    Elife; 2022 Sep; 11():. PubMed ID: 36069759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pax7 as molecular switch regulating early and advanced stages of myogenic mouse ESC differentiation in teratomas.
    Florkowska A; Meszka I; Zawada M; Legutko D; Proszynski TJ; Janczyk-Ilach K; Streminska W; Ciemerych MA; Grabowska I
    Stem Cell Res Ther; 2020 Jun; 11(1):238. PubMed ID: 32552916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional landscape of myogenesis from human pluripotent stem cells reveals a key role of TWIST1 in maintenance of skeletal muscle progenitors.
    Choi IY; Lim H; Cho HJ; Oh Y; Chou BK; Bai H; Cheng L; Kim YJ; Hyun S; Kim H; Shin JH; Lee G
    Elife; 2020 Feb; 9():. PubMed ID: 32011235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous overexpression of Oct4 and Nanog abrogates terminal myogenesis.
    Lang KC; Lin IH; Teng HF; Huang YC; Li CL; Tang KT; Chen SL
    Am J Physiol Cell Physiol; 2009 Jul; 297(1):C43-54. PubMed ID: 19403798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficient genome editing in human pluripotent stem cells through CRISPR/Cas9].
    Liu GG; Li S; Wei YD; Zhang YX; Ding QR
    Yi Chuan; 2015 Nov; 37(11):1167-73. PubMed ID: 26582531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells.
    Cardenas-Diaz FL; Maguire JA; Gadue P; French DL
    J Vis Exp; 2019 Sep; (151):. PubMed ID: 31609348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developing CRISPR/Cas9-Mediated Fluorescent Reporter Human Pluripotent Stem-Cell Lines for High-Content Screening.
    Vojnits K; Nakanishi M; Porras D; Kim Y; Feng Z; Golubeva D; Bhatia M
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic Safe Harbor Expression of PAX7 for the Generation of Engraftable Myogenic Progenitors.
    Kim H; Selvaraj S; Kiley J; Azzag K; Garay BI; Perlingeiro RCR
    Stem Cell Reports; 2021 Jan; 16(1):10-19. PubMed ID: 33275879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineering Skeletal Muscle Grafts with PAX7::GFP-Sorted Human Pluripotent Stem Cell-Derived Myogenic Progenitors on Fibrin Microfiber Bundles for Tissue Regeneration.
    Somers SM; Gilbert-Honick J; Choi IY; K W Lo E; Lim H; Dias S; Wagner KR; Mao HQ; Cahan P; Lee G; Grayson WL
    Bioengineering (Basel); 2022 Nov; 9(11):. PubMed ID: 36421094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cas9 effector-mediated regulation of transcription and differentiation in human pluripotent stem cells.
    Kearns NA; Genga RM; Enuameh MS; Garber M; Wolfe SA; Maehr R
    Development; 2014 Jan; 141(1):219-23. PubMed ID: 24346702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.